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A B S  T R A (3 T  The basic  protein protamine causes  a  rapid  hemolysis when in- 
cubated with the red blood cells of many mammalian  species. The age of the 
cells does not affect the process. Neutralization of the active side groups of the 
protamine  molecule with  formalinization demonstrates  that  a  specific degree 
of charge is necessary for hemolysis, as more than 30 per cent of the guanidine 
groups must remain  unreacted to maintain  activity.  Unlike the hemolysis in- 
duced by the synthetic  polypeptides polylysine and  polyhomoarginine,  prota- 
mine hemolysis is temperature-dependent. 
Whole lipoprotein material derived from red blood cell membranes inhibits 
protamine  hemolysis to  a  greater extent than  do the membranes  themselves, 
serum,  serum  protein fractions,  or  cholesterol.  The  phosphatide  and  protein 
moieties derived from the membranes  are quite avid  in  inhibiting  protamine 
hemolysis.  A  probable  explanation  is  that  intracellular  aggregation  of these 
structural  elements  may  cause  changes  in  electrostatic  charge  and  surface 
tension  which  result  in  increased  permeability. 
The  hemolytic  and  antitumor  cell  properties  of  protamine  could  not  be 
segregated from its animal toxicity. Despite formalinization to a  degree which 
eliminated the former, the compound remained quite toxic to mice and rabbits. 
Protamine is a  basic protein with a molecular weight of approximately 4000 
to 5000 which is separated by salt fraction  (1)  from its complex with desoxy- 
ribonucleic acid in the sperm heads of fish. It is composed of a linear aggrega- 
tion of amino acids and contains a large percentage of arginine. 
It has been previously demonstrated  that protamine  is capable  of inhibit- 
ing protein synthesis in ascites tumor cells following its uptake and combina- 
tion with the cellular nucleic acids (2).  Damage  to the tumor cell membrane 
was minimal  and  the process  was  temperature-dependent.  Protamine  is also 
capable  of producing  hemolysis  in vitro  and  this hemolytic  effect may  repre- 
sent a  factor in its animal  toxicity or another mechanism  of cellular damage. 
In  view  of the  ability  of protamine  to  penetrate  cell  membranes  (2,  3)  it 
appeared  possible that its lysis of red blood cells might result from intracellu- 
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lar activity rather  than  from the surface activity which might  be anticipated 
from  its  highly  charged  structure.  Polylysine polypeptides  of similar  linear 
structure  also  cause  hemolysis  (4).  However,  analysis  of this  reaction  has 
indicated  that  the  hemolysis resulted  from  membrane  binding  of the  poly- 
peptides with no apparent  effect resulting  from  the binding  with non-struc- 
tural  cellular  components.  This  reaction  is  not  temperature-dependent. 
The  following studies were aimed  at  elucidating  the  site of interaction  of 
protamine with red blood cells and  comparing  this reaction with that  of the 
synthetic  polypeptides.  The  conditions  necessary  for  such  interaction  were 
also studied. Attempts were made to segregate the hemolytic and animal toxic 
properties of protamine  from its antitumor  cell action. 
As  in  the  experiments  with  polypeptides,  the  site  of action  of protamine 
was  found  to  be  the  cell's  stromal  material  and  not  an  intracellular  com- 
ponent. The use of purified fractions of the cell stroma revealed that the major 
portion of protamine is bound to the lipoprotein material.  When this lipopro- 
tein  is  further  fractionated,  it  yields  very  active  phosphatide  and  protein 
fractions,  which  in  free  form  bind  protamine  more  avidly  than  the  whole 
lipoprotein.  The  status  of the amino  acids'  side groups was found  to play a 
key role in protamine's  hemolytic ability and also in its antitumor  cell prop- 
erties.  Lastly  a  significant  difference was  demonstrated  between  protamine 
and the polypeptides in that protamine hemolysis was temperature-dependent. 
MATERIALS  AND  METHODS 
25 gin.  white mice were used throughout  the experiments.  Blood was obtained  by 
puncture  of the orbital plexus via  the cornu of the eye and was then washed three 
times  with  twenty volumes of a  high  bicarbonate,  pH  7.4,  balanced  salt  solution 
(BSS) (5).  Incubation was performed in 5 ml. volumetric flasks at 37°C. in a  water 
bath which rotated  the  flasks  at  88 R.V.M., unless otherwise specified.  Hemoglobin 
concentration  was determined  by reading its optical density in solution at 540 m#. 
Adult guinea pigs and albino rabbits were bled via intracardiac puncture and the 
blood was treated as described above. 
Protaminc was obtained from the Biochemical Research Division of the Eli Lilly 
Company as a relatively pure form of salmine sulfate. The protamine was dissolved 
in BSS (usually at 5 mg./ml.)  and dialyzed against BSS (100: l) for  12 hours in the 
cold to remove the sulfate. Up to one-half of the original  nitrogen content was lost 
during  the  procedure.  Nitrogen  determinations  were  performed  by  the  standard 
Kjeldahl method and in most of the experiments the protamine nitrogen concentra- 
tion was used as the standard  measure in expressing concentration.  Nitrogen repre- 
sents roughly one-third  of the weight of the free base  (1). 
Polylysine polypeptide  was  obtained  from  the  Mann  Laboratories,  New  York 
City,  in  the  form  of a  bromide  salt.  The  polypeptide  used  had  an  approximate 
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0-Methyl isourea was obtained from the New  Products Development Group  of 
the American Cyanamid Company. 
Guanidination was carried out on the polylysine according to the procedure of 
Klee and  Richards  (6).  Utilizing the  Callanan variation of the  Sakaguchi color- 
imetric reaction for arginine (7), the final product appeared to contain 60 to 75 per cent 
guanidine groups, with a calculated increase in molecular weight of less than 20 per 
cent. The final product was considered to represent a polypeptide containing 60 to 
75 per cent homoarginine groups with the remaining 20 to 45 per cent as unreacted 
lysine. 
Formalinization of the protamine was performed as described by Fraenkel-Conrat 
(8). Variation in the degree of formalinization was produced by varying the duration 
of incubation, the pH, and the concentration of the protamine. Under the conditions 
described (10 per cent formalin, 80°C., and pH 8)  75 per cent formalinization of a 
1 per cent protamine solution was produced in 4 days and 30 per cent in 24 hours. 
The  loss of the  reactive  side  groups  has  been  explained  as  methylolation of the 
guanidine groups similar to that which can occur with amine groups.  When higher 
concentrations of protamine or  protein  are used,  cross-linkage  can occur  through 
these guanidine groups with condensation of the protamine and increase in molec- 
ular weight up to three times the normal molecular weight or  12,000 (8). 
The purified lipoprotein was prepared by differential ultracentrifugation of human 
erythrocytes and  consists  of peptide,  free  cholesterol,  and  phospholipid  in  about 
equal portions  (9).  Further fractionation was performed by differential separation 
in lipid solvents.  The resulting phosphatide fraction may be considered as  a  pure 
material, while the cholesterol  portion  is  probably contaminated by phosphatide. 
The protein component appears to be a moderately basic  molecule (10). 
Characteristics  of the Hemolytic Process 
When washed red blood cells were incubated with protamine a rapid hemoly- 
sis  ensued.  At  a  red  blood  count  of  150,000  cells/ml,  remarkably  small 
quantities of protamine were found to be capable of producing a  significant 
loss of hemoglobin from each cell. As is shown in Fig.  1, 0.25 ~g. of protamine 
nitrogen/150,000 cells produces 25 per cent hemolysis. The degree of hemoly- 
sis is compared with that produced by distilled water, considered as  100 per 
cent  hemolysis for  these  experiments.  At  this  cell  concentration,  a  tenfold 
increase in protamine  (2.5 ~g.  of protamine nitrogen)  produces a  threefold 
increase in hemolysis, or 75 per cent. 75 per cent hemolysis actually represents 
the maximal ability of protamine to release hemoglobin from this cell con- 
centration and  increases in protamine to concentrations as  high as  250  /~g. 
produce no further increase in  hemoglobin release.  When  examined under 
phase  microscopy the cells showed no crenation,  clumping,  or  gross  mem- 
brane damage and each cell appeared to be equally depleted of hemoglobin. 436  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  44  "  I96I 
Speed of Hemoglobin Release 
When  tested at  the minimal  protamine  concentration  which would produce 
maximal  hemolysis of 150,000 cells  (1.5 ~g.  of protamine nitrogen,  hereafter 
referred  to  as  minimal  hemolyzing  concentration,  MHC)  and  at  a  15-fold 
greater  concentration  of protamine,  hemoglobin  was completely released  in 
10 minutes.  The release was somewhat greater  at  the higher  concentration, 
especially during  the first 5 minutes,  but was almost equivalent at the end of 
the  10 minute period. 
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FIGUI~  1.  The abscissa represents the concentration of protamine nitrogen in micro- 
grams per milliliter; the ordinate, the percentage of hemolysis produced. The red blood 
cell concentration  was  150,000 cells/ml.,  3 times washed. The  flasks were incubated 
for 15 minutes at 37°C., pH 7.4, and rotated at 88 R.P.M. 
Site  of Protamine Action 
A  membrane preparation  was produced from red blood cells by the method 
of Anderson  (11),  which was faintly pink but contained  no whole cells.  The 
addition of small quantities of this preparation  to protamine solutions signifi- 
cantly  reduces  their  hemolytic  ability.  Clumping  and  sedimentation  of the 
membranes  were  noted  and  centrifugation  of  these  membrane  clumps  re- 
moved  protamine  from  the  solutions. 
When the lipoprotein material  of the red blood cell (9,  13)  was added  to 
protamine solutions a  similar,  though more effective, inhibition  of hemolysis 
was produced.  As noted in Fig.  2,  37 per cent inhibition  could be produced 
by a lipoprotein to protamine ratio of 2 : 1. A  ration of 15 : 1 or 60 #g. of lipo- 
protein  to 4/~g.  of protamine  was necessary to produce complete inhibition 
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Fmum~  2.  The  abscissa represents the  micrograms of lipoprotein per  milliliter; the 
ordinate, the  percentage of inhibition of hemolysis induced.  Protamine concentration 
4  #g./ml.  Red blood cell concentration  150,000  ceUs/ml., 3  times washed,  37°(2.  and 
rotated for 15 minutes. 
In order to determine more specifically the site of reaction the stroma was 
further fractionated  (10)  and  the resulting total lipid,  cholesterol, phospha- 
tide,  and  protein  components were  added  to  protamine  solutions  in  equal 
concentration. As is evident from Fig.  3,  the cholesterol fraction was almost 
inactive as a  protamine inhibitor. The activity which was demonstrated was 
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~tc~.~  3.  The  abscissa represents the  concentration  of inhibitor in  micrograms per 
ml.  The ordinate represents  the  percentage of inhibition of hemolysis induced.  Prot- 
amine concentration  in all experiments was  2.5  #g./ml.  Red blood cell concentration 
150,000  cells/m_l.,  3  times  washed  and  incubated  in  rotating  flasks at  37°(2.  for  15 
minutes.  @, cholesterol  fraction.  O,  total  lipid  fraction,  zx,  phosphatide  fraction. A, 
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most probably the result of phosphatide contamination. On the other hand, 
the total lipid was moderately and the phosphatide very active as protamine 
inhibitors.  The total lipid fraction was twice as effective as the original lipo- 
protein, producing total inhibition at a  ratio of 7.5 : 1 while the phosphatide 
was even more reactive throughout the whole range of concentrations. 
A  striking feature was the high degree of reactivity of the protein moiety 
which was the most active component in producing inhibition of hemolysis. 
At a ratio of protein to protamine of 1 : 1, 67.5 per cent inhibition of hemoly- 
sis was produced. 
The doubling of activity of the lipid when freed from its complex with the 
protein may indicate the release of active binding sites.  It was also apparent 
that both the phosphatide and protein material of red blood cell lipoprotein 
react with protamine when  they are in  the form of pure fractions.  Despite 
these findings however, we should only consider the inhibition of protamine 
as  produced  by  the  whole lipoprotein  as  it  is  in  this  form that  these sub- 
stances exist in the membrane. 
Factors  Affecting  the  Hemolytic  Process 
Concentrations of normal mouse serum as low as 0.2  per cent produced 75 
per cent inhibition of hemolysis when protamine was used at MHG, but com- 
parable  concentrations  of serum  albumin  and  globulin  (bovine)  were  less 
than 30 per cent as effective. Constant results were achieved by washing the 
cells three times (BSS  1:60).  Further washings did not increase the suscepti- 
bility of red blood cells and therefore, it appears that the initial concentration 
of adhering  serum was  sufficiently reduced by  this  dilution.  No  structural 
alteration can be deduced save perhaps  that of loss of adhering,  denatured 
globulins. 
This  hemolysis  is  strikingly  temperature-dependent.  Concentrations  of 
protamine which normally would  have  produced  a  50  per  cent hemolysis 
at 37°C.  caused no hemolysis at 0°C.  Under similar conditions  of cold there 
was  no  diminution in  the  hemolytic activity of the  quaternary  compound 
hyamine,  1 polylysine,  or  of polyhomoarginine. 
Changes in the pH of the suspension did not alter the degree of hemolysis. 
No difference in the reaction was noted  when isotonic sodium chloride was 
substituted for a balanced media (BSS).  Glucose was apparently not required 
nor did excess glucose cause inhibition,  and calcium caused  only minor in- 
hibition (less than  10 per cent) when raised to twice the concentration of the 
normal media. 
The ceils of rabbits and guinea pigs were as sensitive to protamine as were 
those of mice. 
I Para  (diisobutyl-cresoxyethoxyethyl)  dimethylbenzylammonium  chloride  monohydrate,  Rohm 
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In an attempt to delineate the possible effects of the age of the cells, a  group 
.of mice was bled repeatedly over a  3  week period and the cells of these mice 
were compared with  those of unprepared  mice for protamine  susceptibility. 
The reticulocyte count of the  "bled"  group  was  I0 per cent.  No differences 
in  protamine  sensitivity could  be detected  at  any concentration  and  it  was 
~oncluded that no cell-age difference in protamine sensitivity existed such as 
has  been  demonstrated  in  primaquine  hemolysis  (12). 
Formalinization 
When a  3 per cent solution of protamine is incubated in  10 per cent formalin, 
pH  7.4-8  at  80°C.  for  4  days,  there  is  an  apparent  doubling  of molecular 
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Fmu~  4.  The  ordinate  represents  the  percentage of hemolysis  induced.  The  red 
blood cell concentration was  150,000/ml.  3 times washed  and incubated at 37°C.  for 
15 minutes.  All protamine preparations (abscissa) were used  at a concentration of 0.5 
/~g. of nitrogen/ml., except G which was 25 #g./ml. 
A, untreated protamine. 
B,  protamine condensate,  molecular weight  10,000, with 40 per  cent free guanidine 
groups. 
C, protamine with normal molecular weight, 80 per cent free guanidine groups. 
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weight  (as determined by dialysis)  and a  reduction of 60 per cent in the free 
guanidine  groups.  As  is  shown  in  Fig.  4  this  material  is  approximately  50 
per  cent more  potent  in  producing  hemolysis  (on  a  weight  basis)  than  un- 
treated protamine.  However, this condensate produces an extensive aggrega- 
tion  of the  red  blood cells,  which  apparently  precedes hemolysis,  not noted 
with untreated protamine. 
When  a  1 per cent solution of protamine was incubated with formalin, no 
increase in molecular weight could be detected but a  reduction in free guani- 44 °  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  44  "  I96I 
dine groups of 25, 40,  and 50 per cent could be produced by varying the in- 
cubation periods. As is demonstrated in Fig. 4 no reduction in hemolytic abil- 
ity could be demonstrated and it was only when a  70 per cent reduction in 
guanidine groups was produced via  methylation that a  sharp and complete 
loss of hemolytic activity occurred. In concentrations of this material  15-fold 
greater than  the  MHC  (25  ~g.  of  protamine  nitrogen/ml.)  no  hemolysis 
occurred. 
This degree of formalinization with a  70 per cent reduction in the reactive 
guanidine groups produced no significant change in the intraperitoneal toxic- 
ity of the treated protamine. On the other hand, its antitumor cell properties 
were completely eliminated by this reduction in  the guanidine groups. 
Mechanism  of Cellular  Alteration 
The avidity of the binding of protamine by the structural elements of the red 
blood cells as well as the rapidity of cell damage indicates that the change 
brought about by protamine was probably structural in nature. In an attempt 
to differentiate between the effects which resulted from such alteration and 
damage which resulted from interference with energy-producing processes, 
the  following experiment was  performed.  Heparin  was  added  to  the  cell- 
protamine suspension at various intervals and one-half of the suspension was 
immediately plunged into an ice bath while the other half continued to in- 
cubate at 37°C.  A  great excess of heparin was added so that the protamine 
which  remained in  solution  would  be  immediately bound.  Preincubation 
of this amount of heparin (1  mg./ml.) with the MHC completely prevented 
hemolysis. Heparin itself in this concentration had no  hemolytic effect and 
incubation at 0°C.  of untreated cells  produced no hemolysis. 
Despite the addition of heparin at 2, 4, and 6 minutes, hemolysis proceeded 
undiminished  at  both temperatures.  Final hemolysis reached  the expected 
65 to 75 per cent in both portions. 
These results confirm the observation  that protamine is  almost instantly 
bound to the cell structure and produces immediately the cellular alteration 
necessary for hemolysis. The continued presence of unreacted protamine is 
not necessary and  the cell changes which are so  produced are sufficient to 
permit hemolysis despite the absence of catabolic activity (at 0°C.). 
DISCUSSION 
Protamine is  capable of producing alterations in  the red blood cell which 
result in a release of up to 85 per cent of the cell's hemoglobin. The release is 
rapid and affects all cells equally. 
The basic polypeptides, especially polylysine, are also capable of producing FREDERICK BECKER  The Hemolytic Properties of Protamine  44x 
hemolysis (4). An analysis of the kinetics of this reaction indicates an interac- 
tion  between  the  cationic  macromolecules and  the  normally  anionic  cell 
surface.  A  probable explanation is  that  the spatial  alteration which  would 
thus be produced would derange the normal permeability. This type of reac- 
tivity has been termed "surface activity." Schulman (14)  has described sur- 
face activity as a combination of a highly charged compound with the charged 
molecules of the cell's surfaces, or in some cases,  a  penetration of the agent 
into the lipoprotein monolayers of the cell with resultant increase in surface 
tension and  increased permeability. 
It  might  be  predicted  from  protamine's  macromolecular  structure  and 
cationic nature  (1)  (dependent upon a  large number of free guanidine side 
groups), that it would demonstrate a  considerable degree of surface activity. 
The experiments demonstrated a clear cut dependence upon the presence of a 
specific number of unreacted side groups, for although the hemolytic ability 
was maintained when the guanidine groups were reduced 50 to 60 per cent, 
it was completely eliminated when they were reduced 70 per cent. The use of 
this maximally reacted protamine in concentrations such that the total num- 
ber of free guanidine groups per cell is equal  to that of a  fully hemolyzing 
concentration of unreacted protamine causes no cell damage. Thus the loss 
of hemolyzing ability is not due solely to the depletion of total charge but to a 
specific charge loss on each protamine molecule probably resulting in a  loss 
of the ability of the molecule to orient itself in a  particular manner on the 
cell's surfaces. A  similar loss of antitumor activity at this juncture is probably 
the result of the loss of protamine's ability to aggregate nucleic acid  (2). 
The  lipoprotein  component of  the  cell  membrane  demonstrates  a  high 
degree  of affinity  for  the  protamine  molecule.  This  binding  undoubtedly 
accounts  for  the  inhibition  of protamine hemolysis induced by  membrane 
preparations and indicates that the hemolysis of red blood ceils most likely 
follows the fixation of protamine within the lipoprotein stroma.  The use of 
purified fractions also demonstrates a  very great affinity of the  phosphatide 
and protein fractions of the lipoprotein for protamine but does not enable us 
to specify which of these moieties might be the binding site in the whole cell. 
Such affinity would be followed by electrostatic alteration and possibly aggre- 
gation of the key structural elements, fibrils and lipid plaques, which would 
distort their regular arrangement and their normal permeability  (15).  Pre- 
vious workers have demonstrated the affinity of lipoproteins for basic proteins 
and  for  other  charged  molecules and  the inhibitory effects  thus  produced 
(16,  17). 
It appears that protamine produces hemolysis by an interaction with the 
anionic components of the cell surface which may reside in the lipoprotein 
component.  Hemoglobin  release  follows  distortion  of  the  normal  electro- 
static structure and possibly structural  alteration.  Protamine,  therefore,  ap- 
pears  to fulfill  the requirements for  a  surface-active  agent. 442  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  44  "  I96I 
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Recdved  for publication, May 31, 1960. 
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